Fortrea
Drayton Virkler is a seasoned executive with extensive experience in the biopharmaceutical and healthcare industries. Currently serving as President and Chief Commercial Officer at Fortrea since May 2023, Drayton previously held leadership roles at Certara, including President of Regulatory & Access, and at IQVIA, where responsibilities included Vice President, Global Head of Go-To-Market for Real World Solutions. Drayton's career began at The Virkler Company, where management of Mexican operations was key. With a strong educational background including an MBA from Duke University and a BS in Chemistry from Washington and Lee University, Drayton has demonstrated expertise in strategic marketing, investor relations, and business development throughout various significant positions in reputable organizations.
This person is not in the org chart
This person is not in any teams
Fortrea
11 followers
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.